A

Annexon Biosciences

Develops C1q inhibitor therapies

Executive Director, Medical and Scientific Writing

Biology & BiotechConfirmed live in the last 24 hours
Full-timeBrisbane, CA, USA

About the Job

Requirements

  • A Bachelor's or Master's degree, or Ph.D./equivalent, in a scientific discipline.
  • At least 12 years of progressive scientific, medical, or technical writing experience, including demonstrated leadership of complex writing initiatives.
  • A strong background and track record of leading the development of high-quality scientific and medical documents for internal and external distribution.
  • Ability to translate complex data into clear, understandable, and compelling written summaries, interpretations, and positions for multiple audiences.
  • Ability to prioritize multiple projects, deliverables, and timelines and exercise thoughtful judgment, problem-solving, and decision-making; ability to identify opportunities for change and improvement with an emphasis on operations and efficiency.
  • Superior attention to detail and thoroughness concerning processes, consistency, grammar, syntax, and scientific accuracy.
  • Computer skills and familiarity with software and cloud programs for document creation, including Microsoft Office and Adobe; sharing and editing, including SharePoint, GraphPad, and Tableau; and data visualization, including Spotfire.
  • Ability to work, communicate, and collaborate with colleagues and external stakeholders in a data-driven, fast-paced environment.

Responsibilities

  • Provide strategic leadership and oversight of critical writing activities across the organization, working cross-functionally to develop and produce high-quality clinical study protocols, investigator brochures, clinical study reports, INDs, CTDs and amendments, analysis and development plans, safety updates and annual reports, narratives and summaries, briefing books, and other research, pre-clinical, CMC, clinical, and regulatory documents.
  • Critically analyze and interpret internal and external non-clinical and clinical data with cross-functional teams to develop strategy, conclusions, and messaging; conduct literature and scientific database searches as needed to support analyses and background summaries.
  • Serve as a senior strategic thought leader on cross-functional teams to develop strategy and approach, ensuring consistency and efficiency in messaging and document organization and contributing scientific knowledge and analytical skills.
  • Lead the development and evolution of scalable medical and scientific writing infrastructure, including resourcing, formats, templates, processes, standards, style guides, workflows, and operating procedures.
  • Oversee departmental resources and budget and collaborate with teams to establish realistic timelines for writing deliverables and program goals.
  • Collaborate with internal and external authors and vendors as needed, providing strategic oversight of operational considerations and ensuring alignment on expectations, milestones, and deliverables.
  • Ensure document content and style adhere to company guidelines and applicable ICH, FDA, EMEA, or other requirements.
  • Support scientific communications as needed, including manuscripts, abstracts, and posters for congresses and external publication.

Desired Qualifications

  • Prior work history at a biotech or pharmaceutical company is preferred; experience in a smaller company environment is ideal.
  • Experience building scientific and medical writing infrastructure and a template repository is a plus.

About the Company

Annexon Biosciences

Develops C1q inhibitor therapies

Annexon Biosciences develops therapies that target the classical complement pathway to treat autoimmune and neurodegenerative diseases, including eye conditions. Its main strategy is to inhibit C1q, the molecule that starts the complement cascade, with the aim of stopping disease progression at its source. The company advances therapies through clinical trials and may either commercialize them or partner with larger pharma firms to bring them to market. Revenue potential comes from product sales, licensing, and milestone payments from collaborations. Annexon’s goal is to deliver first-in-class C1q inhibitors that prevent tissue damage across diseases such as Alzheimer's, Huntington's, glaucoma, and related disorders, supported by substantial financing to push its pipeline forward.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2011

Recently Posted Jobs

Explore more opportunities at Annexon Biosciences

See more jobs